Latest on Pharmaceutical Industry


CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement

CRISPR Therapeutic, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV)-based gene ther..Read More...

Saniona’s SAN711 selected for clinical studies in itching and pain

Saniona, a biotech company focused on CNS and eating disorders, announced today the successful completion of preclinical development of SAN711, for the treatment of chronic itching and neuropathic pain. Preparations for ..Read More...



3D Cell Culture 2019

Copthorne Tara Hotel London Kensington,
United Kingdom,
SMi Group


Medical Japan - Elderly Care & Nursing Expo OSAKA

INTEX Osaka,
Reed Exhibitions Japan Ltd

Press Releases

Pfenex Announces FDA Acceptance of NDA for PF708

Pfenex Inc today announced that the US Food and Drug Administration FDA has accepted for review the 505b2 New Drug Application NDA for the Companys lead product candidate PF708 a Forteo therapeutic equivalent in the trea.. Read More...

EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing today announced that the European Medicines Agency EMA h.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Messe Muenchen India Pvt. Ltd.

Messe Muenchen India Pvt. Ltd. As per the World Bank India has made a substantial effort in attempting to address environmental challenges It has endorsed rigorous environmental legislation and has created relevant institutions to monitor and enforce legislation In response to the threat of climate change the Prime Ministers Nati. Read More...
Bhupinder Singh
Chief Executive Officer